About DSG
DSG, Inc. supports the development of life saving drugs and therapies through clinical trials with a proprietary, organically integrated suite of award-winning eClinical solutions, including its flagship eCaseLink™ EDC, Risk-Based Monitoring, eSource, ePRO, IWRS Randomization and Clinical Supply System, Drug Safety System, and CTMS. Since 1992, DSG has successfully supported thousands of clinical trials for over 400 companies and 25,000 sites across 93 countries, headquartered in Malvern, Pa., with additional offices in the U.S. and Asia. Find out more at www.dsg-us.com.
The Hungarian Biotechnology Association (HBA) was established by Hungary’s leading human biotechnology companies with the aim of promoting the development and representation of the Hungarian biotechnology sector. The Association’s major objectives include obtaining support for the continued development of national life sciences and the commercialization of scientific achievements as well as representing both Hungary and its members at international exhibitions and conferences.
The Enterprise Europe Network helps small business to make the most of the European marketplace, working through local business organisations.
European Network on Gasotransmitters: The biological and medical importance of the endogenously generated gaseous transmitter nitric oxide was recognized by the 1998 Nobel Prize for Medicine/Physiology. It is now clear that several “gasotransmitters” exist and this class of mediators also includes carbon monoxide (CO) and hydrogen sulfide (H2S). Several of the groups leading this research field are based in Europe, thus, the formation of a European network that collates scattered knowledge, resources and expertise on gaseous mediators will encourage the dissemination of innovation, boost collaborations and increase the European competitiveness in this field.
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
The International Society for Heart Research was founded in 1968 in Dubrovnik, as the International Study Group for Research in Cardiac Metabolism. It adopted the name International Society for Heart Research (ISHR) in 1976 in Tokyo. The Society now has over 3,000 members worldwide.
BIO Convention is the most efficient and economical way to find a business partner. Partnering has grown over the past 11 years to become biotech’s largest partnering event, hosting a record breaking 21,000+ partnering meetings in 2011.
Working Group of Cellular Biology is looking for active participants in the field of cell (cardiovascular) biology and physiology. It aims at gathering an active group of basic scientists and clinicians who will work together at developing translational research projects, from signalling molecules to phase II proof-of-concept trials.
BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising start-ups and emerging companies. It is the “must attend” event for getting business done in the biotech industry.